References
- Figge F. H. J., Careg T. N., Weiland G. S. Porphyrin excretion by a patient treated with sulfadiazine and later with sulfanilamide. J. Lab. clin. Med. 1946; 31: 752
- Haeger-Aronsen B. Studies on urinary excretion of delta-aminolaevulic acid and other haem precursors in lead workers and lead-intoxicated rabbits. Scand. J. clin. Lab. Invest. 1960; 12, Suppl. 47
- Haeger-Aronsen B. Various types of porphyria in Sweden. S. Afr. J. Lab. clin. Med. 1963; 9: 288
- Mauzerall D., Granick S. The occurrence and determination of delta-aminolaevulinic acid and porphobilinogen in urine. J. biol. Chem. 1956; 219: 435
- Nakao K., Wada O., Kitamure T., Uono M., Urata G. Activity of amino-laevulic acid synthetase in normal and porphyric human livers. Nature (Lond.) 1966; 210: 838
- Ostle B. Statistic in Research. Iowa State University Press. 1963
- Rimington C., Hemmings A. W. Porphyrinuria following sulphanilamide: sulphanilamide dermatitis. Lancet 1938; I: 770